1 Ostrom, Q. T. et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. Neuro-Oncology20, 1-86, doi:10.1093/neuonc/noy131 (2018).
2 Sun, Y., Wang, Z. & Zhou, D. Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas. Medical Hypotheses81, 319-321, doi:10.1016/j.mehy.2013.04.010 (2013).
3 Li, W. & Graeber, M. B. The molecular profile of microglia under the influence of glioma. Neuro-Oncology14, 958-978, doi:10.1093/neuonc/nos116 (2012).
4 Lin, T.-K. et al. The long non-coding RNA LOC441204 enhances cell growth in human glioma. Scientific Reports7, doi:10.1038/s41598-017-05688-0 (2017).
5 Wang, L. et al. Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray. Molecular Medicine Reports12, 1991-1996, doi:10.3892/mmr.2015.3659 (2015).
6 Kirby, J., Heath, P. R., Shaw, P. J. & Hamdy, F. C. in Advances in Clinical Chemistry, Vol 44 Vol. 44 Advances in Clinical Chemistry (ed G. S. Makowski) 247-292 (2007).
7 Vogelstein, B. et al. Cancer Genome Landscapes. Science339, 1546-1558, doi:10.1126/science.1235122 (2013).
8 Dhamija, S. & Menon, M. B. Non-coding transcript variants of protein-coding genes - what are they good for? Rna Biology15, 1025-1031, doi:10.1080/15476286.2018.1511675 (2018).
9 Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? Cell146, 353-358, doi:10.1016/j.cell.2011.07.014 (2011).
10 Rapicavoli, N. A. et al. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. Elife2, doi:10.7554/eLife.00762 (2013).
11 Chiu, Y.-C., Hsiao, T.-H., Chen, Y. & Chuang, E. Y. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers. Bmc Genomics16, doi:10.1186/1471-2164-16-s4-s1 (2015).
12 Wu, Q. et al. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1. Molecular Oncology12, 799-813, doi:10.1002/1878-0261.12187 (2018).
13 Yao, K., Wang, Q., Jia, J. & Zhao, H. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer. Tumor Biology39, doi:10.1177/1010428317707882 (2017).
14 Shan, Y. et al. LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death & Disease9, doi:10.1038/s41419-018-0759-7 (2018).
15 Sanchez-Mejias, A. & Tay, Y. Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics. Journal of Hematology & Oncology8, doi:10.1186/s13045-015-0129-1 (2015).
16 Qi, X. et al. ceRNA in cancer: possible functions and clinical implications. Journal of Medical Genetics52, 710-718, doi:10.1136/jmedgenet-2015-103334 (2015).
17 Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research43, doi:10.1093/nar/gkv007 (2015).
18 Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research45, W98-W102, doi:10.1093/nar/gkx247 (2017).
19 Lopes, M. B. S. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathologica134, 521-535, doi:10.1007/s00401-017-1769-8 (2017).
20 Lapointe, S., Perry, A. & Butowski, N. A. Primary brain tumours in adults. Lancet392, 432-446, doi:10.1016/s0140-6736(18)30990-5 (2018).
21 Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature465, 1033-U1090, doi:10.1038/nature09144 (2010).
22 Karreth, F. A. et al. In Vivo Identification of Tumor-Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma. Cell147, 382-395, doi:10.1016/j.cell.2011.09.032 (2011).
23 Poliseno, L. & Pandolfi, P. P. PTEN ceRNA networks in human cancer. Methods77-78, 41-50, doi:10.1016/j.ymeth.2015.01.013 (2015).
24 Xu, Z. et al. Integrin beta 1 is a critical effector in promoting metastasis and chemo-resistance of esophageal squamous cell carcinoma. American Journal of Cancer Research7, 531-542 (2017).
25 Sethi, T. et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Medicine5, 662-668, doi:10.1038/9511 (1999).
26 Damiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A. & Dalton, W. S. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines. Blood93, 1658-1667, doi:10.1182/blood.V93.5.1658 (1999).
27 Feng, H. et al. EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. Journal of Clinical Investigation124, 3741-3756, doi:10.1172/jci73093 (2014).
28 Zhong, Z. et al. FNDC3B promotes epithelial-mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment. Oncology Reports39, 1853-1859, doi:10.3892/or.2018.6231 (2018).
29 Zimmerman, J. W. et al. Cancer cell proliferation is inhibited by specific modulation frequencies. British Journal of Cancer106, 307-313, doi:10.1038/bjc.2011.523 (2012).
30 Yamamoto, N. et al. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma. International Journal of Oncology43, 1855-1863, doi:10.3892/ijo.2013.2145 (2013).
31 Zhu, J. et al. Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network. Cancer Research75, 1580-1591, doi:10.1158/0008-5472.Can-14-1027 (2015).
32 Lee, C.-H. et al. The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis. International Journal of Molecular Sciences17, doi:10.3390/ijms17040592 (2016).
33 Rodeberg, D. A., Nuss, R. A., Elsawa, S. F. & Celis, E. Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes. Clinical Cancer Research11, 4545-4552, doi:10.1158/1078-0432.Ccr-04-2235 (2005).
34 Ullio, C. et al. Autophagy of metallothioneins prevents TNF-induced oxidative stress and toxicity in hepatoma cells. Autophagy11, 2184-2198, doi:10.1080/15548627.2015.1106662 (2015).
35 Zhu, C. et al. IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma. Oncotargets and Therapy13, 1129-1143, doi:10.2147/ott.S237162 (2020).
36 Riihila, P. et al. Complement Factor I Promotes Progression of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology135, 579-588, doi:10.1038/jid.2014.376 (2015).
37 Wu, Z. et al. Heat Shock Protein 47 Promotes Glioma Angiogenesis. 26, 31-42, doi:10.1111/bpa.12256 (2016).
38 Kerr, F. K. et al. Elucidation of the substrate specificity of the C1s protease of the classical complement pathway. Journal of Biological Chemistry280, 39510-39514, doi:10.1074/jbc.M506131200 (2005).
39 Vargova, K. et al. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood117, 3816-3825, doi:10.1182/blood-2010-05-285064 (2011).
40 Thiele, J.-A. et al. lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer. International Journal of Molecular Sciences19, doi:10.3390/ijms19092672 (2018).